MediLens Intelligence
Features

医学研究趋势

AI精选本周最具影响力的29个专科论文

最后更新: 2026年5月11日

心脏病学5

影响力 2

Day-of-the-week variation in ischemic stroke admissions in patients with atrial fibrillation.

发表日期: 2026-12-01

Annals of medicine

MediLens 收录日: 2026-05-12

This study investigates the variation in ischemic stroke admissions among patients with atrial fibrillation (AF) based on the day of the week. Analyzing data from the nationwide FinACAF study, which included 13,781 patients with a mean age of 79.2 years, the results show significant differences i...

在PubMed上阅读
影响力 3

Wrist-Measured Nighttime Home BP and Left Ventricular Hypertrophy: The WISDOM-HMOD Study.

发表日期: 2026-05-11

Hypertension (Dallas, Tex. : 1979)

MediLens 收录日: 2026-05-12

The WISDOM-HMOD study evaluated the relationship between nighttime blood pressure measured by a wrist-type monitor and left ventricular hypertrophy in 1218 patients with hypertension or heart failure. Results showed an average nighttime systolic/diastolic BP of 110.5±13.0/63.5±8.8 mm Hg, with 70....

在PubMed上阅读
影响力 3

Gene Therapy for Cardiomyopathy: Tools, Targets, and Trials.

发表日期: 2026-05-11

Circulation. Heart failure

MediLens 收录日: 2026-05-12

This review addresses the significant advancements in cardiac gene therapy for cardiomyopathy, highlighting the transition of adeno-associated virus-mediated gene replacement into early-phase clinical trials. It notes improvements in biomarkers like NT-proBNP and discusses the challenges in deliv...

在PubMed上阅读
影响力 3

Improved Cardiac Function and Glycemic Control in Elderly Diabetic Patients Through Structured Case Management After CABG.

发表日期: 2026-05-11

Medical science monitor : international medical journal of experimental and clinical research

MediLens 收录日: 2026-05-12

This study evaluated the impact of a structured, multidisciplinary case management model on cardiac function and glycemic control in elderly patients with coronary heart disease and diabetes undergoing off-pump CABG. A total of 168 patients were randomized to receive either routine care or an enh...

在PubMed上阅读
影响力 3

Finerenone and Empagliflozin in Type 2 Diabetes.

发表日期: 2026-05-11

Cardiology in review

MediLens 收录日: 2026-05-12

This study highlights the critical role of sodium-glucose cotransporter 2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists in reducing cardiovascular and kidney disease risks in patients with type 2 diabetes. Empagliflozin showed significant benefits in reducing cardiovascular m...

在PubMed上阅读

获取个性化每日摘要

全球医生每天早上以AI文献综述开始新的一天。每早七点通过邮件发送。

开始7天免费试用